Monday, August 24, 2020

Buster

Buster Eye diseases

 Newly Identified Eye Disease In Dogs Can Be Easily Treated

March 8, 2008
Source:
Iowa State University
Summary:

A professor of veterinary medicine has identified and named a previously unknown eye disease. Immune-Mediated Retinopathy, or IMR, causes loss of function in retinal cells and, in some cases, blindness. IMR is very similar to a previously known malady called Sudden Acquired Retinal Degeneration Syndrome or SARDS. Both diseases occur when the dog produces auto antibodies that attack the retinal cells. The antibodies mistake retinal cells for cancerous tumors or tissues that need to be destroyed.

Sinisa Grozdanic, assistant professor of veterinary medicine at Iowa State University, has identified and named an eye disease not previously known. The disease, Immune-Mediated Retinopathy, or IMR, causes loss of function in retinal cells and, in some cases, blindness in canines.

IMR is very similar to a previously known malady called Sudden Acquired Retinal Degeneration Syndrome or SARDS.

Both diseases occur when the dog produces auto antibodies that attack the retinal cells. The antibodies mistake retinal cells for cancerous tumors or tissues that need to be destroyed.

In the process of attacking the retinal cells, the auto antibodies cause the retinal cells to lose function and the dog to lose some or all of its vision.

The difference between IMR and SARDS that Grozdanic identified is that the auto antibodies that attack the retinal cells in SARDS patients are produced in the eye. In the newly identified IMR, Grozdanic found that these auto antibodies are produced elsewhere in the dog and travel to the eyes in the blood.

This is a critical step in treating the disease because the source of the problem is better understood, according to Grozdanic.

"The whole purpose is to start to understand the disease better," he said. "The more we understand these diseases, the more proficient we will be developing new treatments."

Grozdanic says the evidence shows that approximately 2,000 cases of SARDS occur every year. Some of those cases may now be identified as IMR, and treated differently.

Treatment for IMR can have a relatively high success rate. "In approximately 60 percent of the Immune-Mediated Retinopathy cases, we have been able to treat it," he said. "In some cases very successfully, in some cases moderately successfully."

Since IMR has only recently been identified, there are no statistics on how many dogs this disease affects.

Grozdanic has also developed a test to differentiate the two types of retinopathy. Grozdanic shines colored lights in the dog's eyes to see if the pupils constrict. If the pupils constrict poorly while the doctor uses the red light, and have normal constriction when blue light is used, the patient most likely suffers from IMR. If the eyes respond to blue lights, but not red lights, then the diagnosis is SARDS.

Tests show SARDS-affected eyes have almost no electrical activity. IMR-affected eyes have some electrical activity, and the retinal cells are not destroyed but have only lost function. These are the retinal cells that Grozdanic thinks can function again now that the origin of the problem is known.

In his work with canine patients with IMR during the past few years, Grozdanic has restored sight in several dogs.

According to Grozdanic, these two diseases are similar to illnesses that afflict humans, so treatment for people may not be far off.

"This was a giant leap. We are getting better at understanding it, and based on this information, we may be able to modify and improve treatment of dogs and eventually human patients," said Grozdanic.

Grozdanic's findings are published in the March edition of Veterinary Clinics of North America: Small Animal Practice.

https://www.sciencedaily.com/releases/2008/03/080304173310.htm#:~:text=A%20professor%20of%20veterinary%20medicine,Retinal%20Degeneration%20Syndrome%20or%20SARDS.



Cushing’s disease – or hyperadenocorticism – is a condition where the dog’s body produces too much of the hormone ‘cortisol’
Signs your dog may have Cushing’s include drinking lots and urinating frequently, hair loss, weight gain, panting, changes to the skin’s appearance and abdominal swelling – but these can be signs of lots of other health conditions too and many healthy older dogs get a bit of a middle aged spread anyway
Cushing’s is fairly common in middle aged and older dogs. Affected dogs will likely need to take medication to manage the illness for life.
What is Cushing’s disease?
Cushing's disease, or hyperadrenocorticism to give it its proper name, is a condition where the body overproduces the cortisol steroid hormone.  It's a fairly common condition in middle aged and older dogs.

Dogs normally need some steroids for their bodies to function properly and they are produced by the adrenal gland, which sits next to the kidney. The adrenal gland is sent messages to produce cortisol by the pituitary gland, which sits at the base of the brain. If a dog gets a growth on either of these glands, this can send hormone production into overdrive which leads to a number of symptoms.

The majority of Cushing’s cases are caused by a benign tumour on the pituitary gland. Tumours on the adrenal gland also cause this disease, but are less common. High level use of steroids, used to treat immune disorders or allergies, can also cause Cushing’s disease.

Symptoms of Cushing’s disease in dogs
Most owners will notice excess thirst and urination. One of the first signs owners often notice is that their dog suddenly begins needing to go out to the toilet in the middle of the night.

There can also be hair loss, weight gain, panting, skin changes, lowered immunity and abdominal swelling, which can make the belly appear to sag. A lack of energy is another symptom you may notice.

In most cases the symptoms are quite mild and for this reason– along with the fact that there could be other causes of these signs – getting a confirmed diagnosis can be challenging.

https://www.bluecross.org.uk/pet-advice/cushings-disease-in-dogs

No comments:

Post a Comment